Abstract
Incontinentia pigmenti is a multisystem X-linked condition that is male lethal and therefore only affects girls. The condition is characterised by a vesicular erythematous skin rash and affects ectodermal structures (i.e. the skin, hair, teeth and nails). In addition the condition, in about 1/5 of patients, is associated with ocular abnormalities, which resemble exudative vitreoretinopathy and can cause neovascularisation and tractional retinal detachment [1].
Access provided by Autonomous University of Puebla. Download chapter PDF
Similar content being viewed by others
Keywords
- Retinal Detachment
- Ocular Complication
- Retinal Ischaemia
- Ocular Abnormality
- Tractional Retinal Detachment
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
FormalPara MIM Number308310
FormalPara SynonymsBloch-Sulzberger syndrome
1 Definition
Incontinentia pigmenti is a multisystem X-linked condition that is male lethal and therefore only affects girls. The condition is characterised by a vesicular erythematous skin rash and affects ectodermal structures (i.e. the skin, hair, teeth and nails). In addition the condition, in about 1/5 of patients, is associated with ocular abnormalities, which resemble exudative vitreoretinopathy and can cause neovascularisation and tractional retinal detachment [1].
2 Inheritance
IP is a male lethal X-linked condition, which affects girls. (This is sometimes termed X-linked dominant inheritance.) The condition is caused by mutation of the IKBKG (Inhibitor Of Kappa Light Polypeptide Gene Enhancer In B Cells, Kinase Of, Gamma) gene on Xq28, which has also been termed NEMO (NF-Kappa-B Essential Modulator) [2].
About 80 % of mutations result an intragenic recombination that leads to deletion of exons 4–10 of NEMO [3]. For affected females, this will either be a de novo event or is inherited from the mother. In addition, missense mutations, frameshift mutations and nonsense mutations have been described although there is no genotype: phenotype correlation. Because these mutations are cell lethal – and hence lethal to males – they cause 100 % skewing of X-inactivation in the blood of females. NEMO is required for activation by cytokines of the transcription factor nuclear factor kappa B (NFKB). NFKB activation is implicated in inflammation, autoimmunity as well as for the inhibition of apoptosis. NEMO is thus essential in the modulation of immune, inflammatory and apoptotic responses.
3 Epidemiology
The disease is extremely rare with no estimates of prevalence although it is proposed that around 1,000 cases have undergone molecular genetic testing.
4 Clinical Features
Skin: Affected females have an erythematous, blistering rash that manifests at, or soon after, birth. This changes over time to become pigmented. It then fades to leave patchy hypopigmentation in adulthood (Figs. 47.5, 47.7 and 47.8). The areas of pigmentation and depigmentation are linear, following Blaschko’s lines, the paths of embryonic dermal cell migration (Fig. 47.8). The skin eruptions may lead to patchy alopecia.
4.1 Other Extraocular Manifestations
Dental: Hypodontia and microdontia, delayed eruption of teeth (Figs. 47.5 and 47.8).
Nails: Dystrophic nails.
Breast: Abnormalities include breast aplasia, asymmetry and supernumerary nipples [4].
CNS: Although severe neurological abnormalities including seizures and developmental delay are described, they were probably overrepresented in the early literature. They may be more common in those with ophthalmic abnormalities.
Retina: The precise frequency of ocular abnormalities is unclear but is reported in around a fifth of patients [4, 5]. IP2 is associated with defective peripheral retinal vascularisation, which resembles familial exudative vitreoretinopathy or retinopathy of prematurity. Importantly the main risk of ocular complications in infancy and childhood (Figs. 47.1, 47.2, 47.3, 47.4 and 47.6) as with FEVR, the ocular and visual complications are the result of retinal ischaemia which can lead to neovascularisation, tractional retinal detachment and in severe cases the development of a vascularised retrolental mass. IP2 is therefore one of the differential diagnoses of leucocoria. Defective foveal vascularisation can cause macular ischaemia/neovascularisation.
The variable nature of the ophthalmic abnormalities in IP2 and the real risk of bilateral disease are such that it is recommended that all affected girls are screened during early life, either being examined under anaesthesia or using indirect ophthalmoscopy. There are no official guidelines for screening although a frequent (monthly) review in the first months of life, and slightly less frequently (around 3 monthly) until around the age of three years has been proposed [6, 7]. In affected eyes there is abnormal retinal vascularisation with peripheral areas of avascularity, which may be visualised directly or with fluorescein angiography. There are no characteristic electroretinographic abnormalities.
5 Variants of IP2
IP is a truly monogenic condition, which is extremely rare. The condition may be distinguished from ROP and Norrie disease/FEVR on the basis of the systemic abnormalities. A small number of affected males have been described either with Klinefelter syndrome (47, XXY) or as a result of somatic mosaicism of the pathogenic mutations in IKBKG [8, 9].
6 Evolution
Like ROP and FEVR, the ocular manifestations of IP2 are highly variable. Unfortunately, the natural history can be severe and bilateral in a small but significant number of cases. Retinal ischaemia can lead to neovascularisation, retinal traction, macular ectopia, falciform retinal folds and total retinal detachment with a ‘pseudoglioma’ appearance. IP2 is a differential diagnosis of leucocoria.
7 Diagnosis and Differential Diagnosis
A diagnosis of IP2 syndrome must be excluded in those with an appearance of FEVR/ROP. The condition may be diagnosed in young girls with a characteristic history of the typical skin rash. Therefore IP2 must, like FEVR, be suspected in those with retinal folds, exudative or tractional retinal detachment, macular ectopia or straightened retinal vessels. The differential diagnosis includes:
ROP: The retinal appearance of IP2 results from a defect in the vascularisation of the developing retinal, in particular at its periphery, and is similar to retinopathy of prematurity (ROP).
Persistent Hyperplastic Primary Vitreous (PHPV): At the more severe end of the spectrum severe IP2, FEVR, Norrie disease and OPPG are all are associated with a severe retinal phenotype that mimics persistent hyperplastic primary vitreous (PHPV).
8 Treatment
Individuals with suspected or proven IP2 require full retinal examination and screening over the first years of life. This should be undertaken using indirect ophthalmoscopy with scleral indentation. Like FEVR individuals require management of secondary complications of peripheral retinal ischaemia, for example, using laser of cryotherapy to manage neovascularisation and surgery to treat retinal detachment. The use of anti-VEGF treatments has been described.
Summary for the Clinician
-
IP2 is a very rare male lethal X-linked condition that affects girls.
-
The condition is caused by mutations in the iIKBKG gene on Xq28.
-
In around 1/5 patients, ocular complications resemble ROP or FEVR as a consequence of defective peripheral retinal vascularisation.
-
All children with suspected IP2 should be screened regularly in early life.
-
Like FEVR, ocular complications result from abnormal development of retinal vasculature. The secondary consequences of retinal ischaemia cause retinal damage and visual loss.
References
Hadj-Rabia S, Froidevaux D, Bodak N, Hamel-Teillac D, Smahi A, Touil Y, Fraitag S, de Prost Y, Bodemer C. Clinical study of 40 cases of incontinentia pigmenti. Arch Dermatol. 2003;139:1163–70.
Smahi A, Courtois G, Vabres P, Yamaoka S, Heuertz S, Munnich A, Israël A, Heiss NS, Klauck SM, Kioschis P, Wiemann S, Poustka A, Esposito T, Bardaro T, Gianfrancesco F, Ciccodicola A, D’Urso M, Woffendin H, Jakins T, Donnai D, Stewart H, Kenwrick SJ, Aradhya S, Yamagata T, Levy M, Lewis RA, Nelson DL. Genomic rearrangement in NEMO impairs NF-kappaB activation and is a cause of incontinentia pigmenti. The International Incontinentia Pigmenti (IP) Consortium. Nature. 2000;405(6785):466–72.
Aradhya S, Woffendin H, Jakins T, Bardaro T, Esposito T, Smahi A, Shaw C, Levy M, Munnich A, D’Urso M, Lewis RA, Kenwrick S, Nelson DL. A recurrent deletion in the ubiquitously expressed NEMO (IKK-gamma) gene accounts for the vast majority of incontinentia pigmenti mutations. Hum Mol Genet. 2001;10:2171–9.
Badgwell AL, Iglesias AD, Emmerich S, Willner JP. The natural history of incontinentia pigmenti as reported by 198 affected individuals. Abstract 38. Nashville: American College of Medical Genetics Annual Meeting; 2007.
Fusco F, Paciolla M, Pescatore A, Lioi MB, Ayuso C, Faravelli F, Gentile M, Zollino M, D’Urso M, Miano MG, Ursini MV. Microdeletion/duplication at the Xq28 IP locus causes a de novo IKBKG/NEMO/IKKgamma exon4_10 deletion in families with incontinentia pigmenti. Hum Mutat. 2009;30:1284–91.
Holmstrom G, Thoren K. Ocular manifestations of incontinentia pigmenti. Acta Ophthalmol Scand. 2000;78:348–53.
O’Doherty M, Mc Creery K, Green AJ, Tuwir I, Brosnahan D. Incontinentia pigmenti–ophthalmological observation of a series of cases and review of the literature. Br J Ophthalmol. 2011;95:11–6.
Buinauskaite E, Buinauskiene J, Kucinskiene V, Strazdiene D, Valiukeviciene S. Incontinentia pigmenti in a male infant with Klinefelter syndrome: a case report and review of the literature. Pediatr Dermatol. 2010;27:492–5.
Kenwrick S, Woffendin H, Jakins T, Shuttleworth SG, Mayer E, Greenhalgh L, Whittaker J, Rugolotto S, Bardaro T, Esposito T, D’Urso M, Soli F, Turco A, Smahi A, Hamel-Teillac D, Lyonnet S, Bonnefont JP, Munnich A, Aradhya S, Kashork CD, Shaffer LG, Nelson DL, Levy M, Lewis RA. International IP Consortium. Survival of male patients with incontinentia pigmenti carrying a lethal mutation can be explained by somatic mosaicism or Klinefelter syndrome. Am J Hum Genet. 2001;69(6):1210–7. Epub 2001 Oct 22.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Black, G.C.M. (2014). Incontinentia Pigmenti Type II (IP2). In: Puech, B., De Laey, JJ., Holder, G. (eds) Inherited Chorioretinal Dystrophies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-69466-3_47
Download citation
DOI: https://doi.org/10.1007/978-3-540-69466-3_47
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-69464-9
Online ISBN: 978-3-540-69466-3
eBook Packages: MedicineMedicine (R0)